Literature DB >> 23271613

Leflunomide-induced DRESS syndrome with renal involvement and vasculitis.

Benzeeta Pinto1, Varun Dhir, Sabari Krishnan, Ritambhra Nada.   

Abstract

DRESS or drug reaction (or rash) with eosinophilia and systemic symptoms belongs to the severe cutaneous adverse reaction group and is characterized by hematological abnormalities and visceral organ involvement. Although most often related with anticonvulsant and sulfonamide use, it is reported with numerous other drugs. We report an unusual case of DRESS syndrome due to Leflunomide, also complicated by renal involvement in the form of granulomatous interstitial nephritis and vasculitis. On a review of the literature, eight similar cases were found, and these are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23271613     DOI: 10.1007/s10067-012-2152-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  19 in total

1.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  S H Kardaun; A Sidoroff; L Valeyrie-Allanore; S Halevy; B B Davidovici; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

2.  Allopurinol-induced DRESS syndrome with a histologic pattern consistent with interstitial granulomatous drug reaction.

Authors:  Mi Sun Kim; June Hyunkyung Lee; Kun Park; Sook-ja Son
Journal:  Am J Dermatopathol       Date:  2014-02       Impact factor: 1.533

3.  Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases.

Authors:  G Do-Pham; A Charachon; T A Duong; A W Thille; N Benhaiem; M Bagot; O Chosidow; J C Roujeau; P Wolkenstein; L Valeyrie-Allanore
Journal:  Br J Dermatol       Date:  2011-07       Impact factor: 9.302

4.  Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.

Authors:  D L Scott; J S Smolen; J R Kalden; L B van de Putte; A Larsen; T K Kvien; M Schattenkirchner; P Nash; C Oed; I Loew-Friedrich
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

Review 5.  Leflunomide: mode of action in the treatment of rheumatoid arthritis.

Authors:  F C Breedveld; J M Dayer
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

6.  Vasculitis occurring during leflunomide therapy.

Authors:  E A Holm; E Balslev; G B Jemec
Journal:  Dermatology       Date:  2001       Impact factor: 5.366

7.  An unusual case of DRESS syndrome due to leflunomide.

Authors:  Arvind Kumar Vaish; Anil Kumar Tripathi; Lokesh Kumar Gupta; Nirdesh Jain; Abhishek Agarwal; Sudhir Kumar Verma
Journal:  BMJ Case Rep       Date:  2011-09-04

8.  Vasculitis associated with the use of leflunomide.

Authors:  Jeannie Macdonald; Toni Zhong; Adriana Lazarescu; Bing Siang Gan; Manfred Harth
Journal:  J Rheumatol       Date:  2004-10       Impact factor: 4.666

9.  A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis.

Authors:  Jean-François Augusto; Johnny Sayegh; Amélie Simon; Anne Croue; Jean-Marie Chennebault; Maud Cousin; Jean-François Subra
Journal:  Nephrol Dial Transplant       Date:  2009-06-09       Impact factor: 5.992

10.  [Leflunomide-induced skin necrosis].

Authors:  C Gros; F Delesalle; S Gautier; E Delaporte
Journal:  Ann Dermatol Venereol       Date:  2008-03-04       Impact factor: 0.777

View more
  6 in total

1.  Persistent eosinophilia in rheumatoid arthritis: a prospective observational study.

Authors:  Dantis Emmanuel; Subhash Chandra Parija; Ankit Jain; Durga Prasanna Misra; Rakhee Kar; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2018-11-13       Impact factor: 2.631

Review 2.  [Interstitial nephritis in rheumatic diseases].

Authors:  P Korsten; G A Müller
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

3.  The Anti-Rheumatic Drug, Leflunomide, Induces Nephrotoxicity in Mice via Upregulation of TGFβ-Mediated p53/Smad2/3 Signaling.

Authors:  Alhanouf A Aljohani; Yasmeen S Alqarni; Maram N Alrashidi; Maha H Aljuhani; Shaimaa A Shehata; Mohamed K El-Kherbetawy; Kousalya Prabahar; Reem Alshaman; Abdullah Alattar; Ahmed M N Helaly; Hayam Ateyya; Ezzat A Ismail; Sawsan A Zaitone
Journal:  Toxics       Date:  2022-05-23

Review 4.  Eosinophilic Drug Allergy.

Authors:  Merin Kuruvilla; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

Review 5.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.

Authors:  Marwan H Adwan
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.686

Review 6.  Drug-induced impairment of renal function.

Authors:  George Sunny Pazhayattil; Anushree C Shirali
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.